Clinical trials referral resource. Current clinical trials investigating 3-AP.
Low
Jennifer A
JA
National Cancer Institute, Bethesda, MD, USA.
Schoenfeldt
Mason
M
D002453:Cell Cycle; D002986:Clinical Trials as Topic; D004249:DNA Damage; D004334:Drug Administration Schedule; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D011725:Pyridines; D013882:Thiosemicarbazones; C078157:3-aminopyridine-2-carboxaldehyde thiosemicarbazone; D012264:Ribonucleotide Reductases